Washington [US]: The US Food and Drug Administration (FDA) has authorized the emergency use of the third dose of both Moderna and Pfizer vaccines against COVID-19 for immunocompromised people.
“The country has entered yet another wave of the COVID-19 pandemic, and the FDA is especially cognizant that immunocompromised people are particularly at risk for severe disease. After a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from a third dose of the Pfizer-BioNTech or Moderna Vaccines,” acting FDA Commissioner Janet Woodcock said on late Thursday, as quoted by the body’s statement. “Today’s action allows doctors to boost immunity in certain immunocompromised individuals who need extra protection from COVID-19. As we’ve previously stated, other individuals who are fully vaccinated are adequately protected and do not need an additional dose of COVID-19 vaccine at this time,” Woodcock added.
Must Read
- Telangana Governor urges people to take 2nd dose of COVID-19…
- Telangana Governor urges people to take 2nd dose of COVID-19…
- Goa achieved 100% first dose Covid vaccination, target set…
- Zydus Cadila to seek approval for two-dose regimen of its…
- No provision for taking 3rd dose of COVID-19 vaccine: Centre…
- Meerut: Over 2 lakh people due for second dose of COVID-19…
- 'Vaccination Mela' in Dehradun: People to win prizes for…
- People dropping out of taking second dose of COVID vaccine…
- Tripura: Over 4 lakh people haven't taken 2nd COVID vaccine…
- 77 lakh people without ID cards administered 1st dose of…